+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Blood Glucose Monitoring Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 -2027

  • ID: 5021842
  • Report
  • March 2020
  • Region: Global
  • 258 pages
  • Transparency Market Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott
  • AgaMatrix
  • B.Braun Melsungen AG
  • F. Hoffmann-La Roche Ltd
  • Medtronic
  • Sanofi-aventis
  • MORE
Blood Glucose Monitoring Systems Market - Scope of the Report

The publisher’s report on the global blood glucose monitoring systems market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2019 to 2027. The report provides the revenue of the global blood glucose monitoring systems market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global blood glucose monitoring systems market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ device literature, annual reports, press releases, and relevant documents to understand the global blood glucose monitoring systems market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomenon in the global blood glucose monitoring systems market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global blood glucose monitoring systems market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global blood glucose monitoring systems market.

The report delves into the competitive landscape of the global blood glucose monitoring systems market. Key players operating in the global blood glucose monitoring systems market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOTs are some of the attributes of players in the global blood glucose monitoring systems market that have been profiled in this report.

Key Questions Answered in Blood Glucose Monitoring Systems Market Report
  • What is the scope of growth of devices and its companies in the blood glucose monitoring systems market and its application sector?
  • What will be the Y-o-Y growth of the global blood glucose monitoring systems market between 2019 and 2027?
  • What is the influence of changing trends in technologies on the global blood glucose monitoring systems market?
  • Will Americas continue to be the most profitable regional market for global primary immunodeficiency therapy providers?
  • Which factors will impede the growth of the global blood glucose monitoring systems market during the forecast period?
  • Which are the leading companies in the global blood glucose monitoring systems market?
Research Methodology

A unique research methodology has been utilized by the publisher to conduct a comprehensive research on the growth of the global blood glucose monitoring systems market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary sources referred to by analysts during the global blood glucose monitoring systems market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, device portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the study on the global blood glucose monitoring systems market’s primary sources.

These primary and secondary sources have provided exclusive information during interviews, which serves as a validation from blood glucose monitoring systems market leaders. Access to extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global blood glucose monitoring systems market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped in reaching the publisher’s estimates on future prospects of the global blood glucose monitoring systems market more reliably and accurately.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Abbott
  • AgaMatrix
  • B.Braun Melsungen AG
  • F. Hoffmann-La Roche Ltd
  • Medtronic
  • Sanofi-aventis
  • MORE
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Blood Glucose Monitoring Systems Market

4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.4. Global Blood Glucose Monitoring Systems Market Analysis and Forecast, 2017–2027
4.5. Porter’s Five Force Analysis

5. Key Insights
5.1. Price Analysis
5.2. Disease Prevalence & Incidence Rate Globally with Key Countries
5.3. Key Vendor and Distributor Analysis
5.4. Reimbursement Scenario by Region/Globally
5.5. Supply Chain Analysis, by Country (Market Structure)
5.6. Marketing Strategies and Promotional Activities

6. Global Blood Glucose Monitoring Systems Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2027
6.4. Market Attractiveness, by Product Type

7. Global Blood Glucose Monitoring Systems Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2027
7.4. Market Attractiveness, by Application

8. Global Blood Glucose Monitoring Systems Market Analysis and Forecast, by Testing Site
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Testing Site, 2017–2027
8.4. Market Attractiveness, by Testing Site

9. Global Blood Glucose Monitoring Systems Market Analysis and Forecast, by Patient Care Settings
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by Patient Care Settings, 2017–2027
9.4. Market Attractiveness, by Patient Care Settings

10. Global Blood Glucose Monitoring System Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.3. Market Attractiveness, by Country/Region

11. Americas Blood Glucose Monitoring System Market Analysis and Forecast
11.1. Introduction
11.2. Market Value Forecast, by Product Type, 2017–2027
11.3. Market Value Forecast, by Application, 2017–2027
11.4. Market Value Forecast, by Testing Site, 2017–2027
11.5. Market Value Forecast, by Patient Care Settings, 2017–2027
11.6. Market Value Forecast, by Country/Sub-region, 2017–2027
11.7. Market Attractiveness Analysis
11.8. Market Share Analysis by Region for Big and Mid-sized Players

12. Europe Blood Glucose Monitoring System Market Analysis and Forecast
12.1. Introduction
12.2. Market Value Forecast, by Product Type, 2017–2027
12.3. Market Value Forecast, by Application, 2017–2027
12.4. Market Value Forecast, by Testing Site, 2017–2027
12.5. Market Value Forecast, by Patient Care Settings, 2017–2027
12.6. Market Value Forecast, by Country/Sub-region, 2017–2027
12.7. Market Attractiveness Analysis
12.8. Market Share Analysis by Region for Big and Mid-sized Players

13. Asia Pacific Blood Glucose Monitoring System Market Analysis and Forecast
13.1. Introduction
13.2. Market Value Forecast, by Product Type, 2017–2027
13.3. Market Value Forecast, by Application, 2017–2027
13.4. Market Value Forecast, by Testing Site, 2017–2027
13.5. Market Value Forecast, by Patient Care Settings, 2017–2027
13.6. Market Value Forecast, by Country/Sub-region, 2017–2027
13.7. Market Attractiveness Analysis
13.8. Market Share Analysis by Region for Big and Mid-sized Players

14. Middle East & Africa Blood Glucose Monitoring System Market Analysis and Forecast
14.1. Introduction
14.2. Market Value Forecast, by Product Type, 2017–2027
14.3. Market Value Forecast, by Application, 2017–2027
14.4. Market Value Forecast, by Testing Site, 2017–2027
14.5. Market Value Forecast, by Patient Care Settings, 2017–2027
14.6. Market Value Forecast, by Country/Sub-region, 2017–2027
14.7. Market Attractiveness Analysis
14.8. Market Share Analysis by Region for Big and Mid-sized Players

15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis, by Company (2018)
15.3. Company Profiles
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Abbott
  • Medtronic
  • F. Hoffmann-La Roche Ltd
  • B.Braun Melsungen AG
  • AgaMatrix
  • Sanofi-aventis
  • SD Biosensor, INC
  • LifeScan
  • Ascensia Diabetes Care
  • Prodigy Diabetes Care, LLC
  • Nipro
  • Dexcom, Inc.
  • Ypsomed AG
  • ACON Laboratories, Inc
  • Senseonics
Note: Product cover images may vary from those shown
Adroll
adroll